IMRIS nets FDA OK for 3T MRI

Canadian intraoperative MRI technology developer IMRIS of Winnipeg, Manitoba, has received clearance from the U.S. Food and Drug Administration (FDA) for its 3-tesla IMRISneuro.

IMRISneuro is now available with either a 1.5-tesla or 3-tesla magnet. Both versions utilize an MRI system from Siemens Healthcare of Malvern, PA.

Related Reading

IMRIS names Rice to U.S. sales post, May 30, 2008

IMRIS signs UVA, May 14, 2008

IMRIS receives Oregon order, April 28, 2008

IMRIS wins Chinese contract for MR suite, February 1, 2008

IMRIS completes IPO, November 2, 2007

Copyright © 2008

Page 1 of 607
Next Page